Genomic analysis of comprehensive next generation sequencing data to explore the criteria for MET amplification as an actionable biomarker in NSCLC.
Tsui DCC, Lee JK, Tambaoan CFB, Hughes J, Fendler B, Decker B, Frampton GM, Schrock AB, Camidge DR. Genomic analysis of comprehensive next generation sequencing data to explore the criteria for MET amplification as an actionable biomarker in NSCLC. Lung Cancer. 2025 Jan; 199:108081.